This information is produced and provided originally by the National Cancer Institute (NCI). We only provide general information and advice from medical professionals should be followed. More information is available on the NCI-website at www.cancer.gov. This information was last updated by NCI in July 2014.
Cancer that forms in tissues of one or both testicles. Testicular cancer is most common in young or middle-aged men. Most testicular cancers begin in germ cells (cells that make sperm) and are called testicular germ cell tumors.
The Anticancer Fund content will follow shortly. Following link will provide you with reliable information.
Standard of care
Cancer of the testicle
Tumor of the testicle
Tumour of the testicle
Cancer of the testis
Tumour of the testis
Tumor of the testis
Therapies by type
The following list of treatments is based on what we have found in scientific studies about cancer. More information about the listed therapies can be found under the tab THERAPIES. For registered drugs, radiotherapy and surgical interventions, approval by the authorities is given.
A clinical trial is a research study conducted with patients to evaluate whether a new treatment is safe (safety) and whether it works (efficacy). Clinical trials are performed to test the efficacy of drugs but also non-drug treatments such as radiotherapy or surgery and combinations of different treatments. Clinical trials take place in all kinds of hospitals and clinics, but mostly in academic hospitals. They are organized by researchers and doctors.
The Anticancer Fund provides a tool to search for phase III clinical trials by type of cancer and by country. For Belgium, the Netherlands, Switzerland, Luxembourg, France and the UK, the Anticancer Fund provides contacts to get more information about the phase III clinical trials currently ongoing. Discuss the possibilities of participating in one of these clinical trials with your doctor.
The list of the phase III clinical trials for testicular cancer is available here.